Family Legacy Financial Solutions LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 23,793 shares of the company's stock, valued at approximately $1,459,000. Doximity makes up about 1.2% of Family Legacy Financial Solutions LLC's investment portfolio, making the stock its 18th largest holding.
Other hedge funds have also made changes to their positions in the company. VSM Wealth Advisory LLC purchased a new stake in Doximity during the 1st quarter worth $29,000. Allworth Financial LP raised its holdings in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI purchased a new position in shares of Doximity in the first quarter worth approximately $33,000. Spire Wealth Management grew its position in Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after acquiring an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group grew its position in Doximity by 70.7% in the first quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after acquiring an additional 309 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.
Insider Transactions at Doximity
In other news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director directly owned 16,618 shares in the company, valued at $948,721.62. The trade was a 10.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction on Friday, September 12th. The stock was sold at an average price of $70.50, for a total value of $352,500.00. Following the sale, the director owned 19,839 shares in the company, valued at $1,398,649.50. The trade was a 20.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 37,000 shares of company stock worth $2,281,880 in the last ninety days. Company insiders own 31.30% of the company's stock.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. JPMorgan Chase & Co. cut their target price on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research note on Tuesday, May 27th. BTIG Research raised shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target on the stock in a report on Monday, June 2nd. Needham & Company LLC boosted their price target on shares of Doximity from $67.00 to $75.00 and gave the company a "buy" rating in a report on Friday, August 8th. Zacks Research lowered shares of Doximity from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Finally, Truist Financial upped their target price on shares of Doximity from $52.00 to $61.00 and gave the stock a "hold" rating in a report on Thursday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $67.42.
Check Out Our Latest Analysis on Doximity
Doximity Stock Down 0.9%
NASDAQ:DOCS traded down $0.65 during trading hours on Monday, hitting $72.17. 412,274 shares of the company traded hands, compared to its average volume of 2,196,105. The firm's 50-day simple moving average is $64.76 and its 200-day simple moving average is $59.92. Doximity, Inc. has a one year low of $40.57 and a one year high of $85.21. The company has a market cap of $13.52 billion, a PE ratio of 72.12, a PEG ratio of 4.10 and a beta of 1.37.
Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The company's revenue for the quarter was up 15.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.
About Doximity
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.